<- Back to digest

JSES - 2026-06-01 - Journal Article

Survival and long-term (minimum 10-year) outcomes of bony increased-offset-reverse shoulder arthroplasty.

Secci G, Mouchantaf M, Biegun M, Schippers P, Chelli M, Boileau P

retrospective cohortLOE IIIn = 196 shoulders (192 patients); 104 shoulders with complete long-term follow-upMean 12.7 years (range 10–18 years)

Topics

shoulder elbowbasic science
PMID: 41475472DOI: 10.1016/j.jse.2025.11.028View on PubMed ->

Key Takeaway

BIO-RSA achieves 98% prosthesis survival at mean 12.7 years with 95% complete bone graft incorporation, and zero instability events, though severe scapular notching occurred in 32% of shoulders.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This single-center retrospective study with prospectively collected data evaluated survival and long-term outcomes of BIO-RSA in 196 shoulders treated for osteoarthritis with cuff deficiency between 2006 and 2014. At minimum 10-year follow-up, Kaplan-Meier survival with revision as endpoint was 98%; 4 revisions occurred (3 for glenoid loosening, 1 for periprosthetic fracture), all glenoid failures occurred within 5 years, and CT confirmed full graft incorporation in 95% of assessed shoulders. Severe scapular notching (grade 3–4) was present in 32% and was significantly associated with superior glenoid tilt (P=.002), while no dislocations occurred and acromial/scapular spine fractures were observed in only 2%.

Key Limitation

Radiographic and CT analysis was performed on only 41 of 104 available shoulders (39%), introducing selection bias into the structural outcome data including graft incorporation and notching rates.

Original Abstract

BACKGROUND

Bony increased-offset-reverse shoulder arthroplasty (BIO-RSA) has shown promising short- to medium-term results; however, long-term outcomes are lacking. The goal of the present study was to report on survival and long-term (minimum 10-year follow-up) outcomes of BIO-RSA.

METHODS

Retrospective single-center study with prospectively collected data, including 192 patients (196 shoulders) who underwent primary BIO-RSA for the treatment of osteoarthritis with cuff deficiency between 2006 and 2014. Mean age at surgery was 73 ± 7 years, and 70% were female. A structural bone graft, harvested from the humeral head, was fixed on the glenoid with a long-post baseplate, and a Grammont-type (Aequalis Reversed II [Tornier], 155° of neck-shaft angle) prosthesis was used. At a minimum of 10 years, 55 patients died, 31 were lost to follow-up, and 6 patients had dementia, leaving 100 patients (104 shoulders) to assess long-term clinical and subjective results. Graft incorporation, scapular notching, and glenoid inclination correction were assessed on 41 shoulders who accepted to come back for radiographic and computed tomographic (CT) scan analysis. The mean follow-up was 12.7 years (10-18 years).

RESULTS

The 10-year prosthesis survival, using Kaplan-Meier method with revision as end point, was 98% (95% confidence interval 94%-99%). Among the 196 BIO-RSAs performed, 4 (2%) were revised: 1 for traumatic postoperative humeral fracture and 3 for glenoid loosening. Glenoid loosening occurred in 5 cases (2.5%): 3 cases of aseptic loosening (all with superior tilt of the glenoid), 1 case of septic loosening, and 1 case of traumatic glenoid mobilization; there was no glenoid failure after 5 years. On the last follow-up CT scan images, we observed full integration of the bone graft without resorption in 95% (39/41). Severe (grade 3 or 4) scapular notching occurred in 32% and was associated with superior glenoid tilt (P = .002). At last follow-up, no prosthesis dislocation was reported, and acromial/scapular spine fractures occurred in 2%. The mean Constant score was 72 ± 14 points and mean Subjective Shoulder Value 80% ± 18%. Overall, 93% (98/104) were satisfied and stated that they would undergo the procedure again, if needed.

CONCLUSION

The BIO-RSA is a safe and durable surgical procedure, with 98% of prosthesis survival rate at a mean follow-up of 12.7 years (10-18 years) and 95% of complete bone graft incorporation. Bony lateralization does not increase the risk of glenoid loosening or acromial/scapular spine fractures, although it protects from prosthetic instability. Superior glenoid tilt is a risk factor for scapular notching and baseplate loosening and should be corrected.